Capital Flow Monitor · Sponsors · CIK 2155613
Way Biosolutions, Inc.
20 ACORN PARK DRIVE, CAMBRIDGE, MA, 02140 · 5082907699
Biotechnology · Corporation· inc. DELAWARE true 2024
Fit score
—
Offering
$2.0M
Sold
$2.0M
% sold
100.0%
Investors
2
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | D ·current | 506(b) | $2.0M | $2.0M | 100.0% | 2 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Huaibin Zhang — Executive Officer / Director, Cambridge, MA
- David R. Walt — Director, Cambridge, MA
-
Paul Meister — Director, Cambridge, MA
5 other raises
- Everest Biolabs, Inc. $4.4M of $5.7M · 77.0%
- GCM Grosvenor Credit Secondaries Structured Note 2025, L.P. $625.0M of —
- GCM Grosvenor Credit Secondaries Structured Note 2025 Feeder, L.P. $10.4M of —
- Flywheel Exchange Inc. $16.4M of $27.4M · 59.7%
- BlueWhale Bio, Inc. $5.0M of $15.0M · 33.3%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.